JPRN-UMIN000016998招募中未知
Effect of Tolvaptan on polycystic liver and kidney is autosomal dominant polycystic kidney disease - GLSG ADPKD
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine0 个研究点目标入组 5 人开始时间: 2020年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patient having a history of allergy to Tolvaptan or its analog. 2. The patient cannot feel thirsty or is unable to consume liquid. 3. The patient with hypernatremia. 4. The patient with severe renal function (less than eGFR 15mL/min/1.73m2). 5. The patient with chronic hepatitis or drug-induced liver injury of the history of these disease (except liver cysts). 6. The pregnant woman or the woman who has the possibility of the pregnancy. 7. The patient whom the primary doctor think not appropriate for participating the trial.
研究者
相似试验
尚未招募
4 期
Does the drug Tolvaptan have any effect on decreasing the total kidney volume in patients with autosomal dominant polycystic kidney diseaseCTRI/2019/11/022099DrAnjana Asokan
进行中（未招募）
1 期
Same as aboveMedDRA version: 20.0Level: LLTClassification code 10036045Term: Polycystic kidneySystem Organ Class: 100000004850Autosomal Dominant Polycystic Kidney DIseaseEUCTR2017-004115-39-DKordsjællands Hospital, Department of Cardiology, Nephrology and Endocrinology90
已完成
不适用
Effect of tolvaptan in decompensated liver cirrhosis patientsJPRN-UMIN000016188shonan kamakura general hospital50
进行中（未招募）
1 期
The effects of tolvaptan on renal handeling of water and salt, hormones in the blood and the circulation, during blocking of the nitric oxide (NO) system in healthy subjects. A dose-response study.HyponatremiaSIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)MedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 100000004860EUCTR2013-003800-38-DKDepartment of Medical Research22
已完成
不适用
The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failurecongestive heart failureJPRN-UMIN000014134ishiarai Heart Center Hospital80